Your browser doesn't support javascript.
loading
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy.
Reschke, Robin; Gussek, Philipp; Boldt, Andreas; Sack, Ulrich; Köhl, Ulrike; Lordick, Florian; Gora, Thomas; Kreuz, Markus; Reiche, Kristin; Simon, Jan-Christoph; Ziemer, Mirjana; Kunz, Manfred.
Afiliação
  • Reschke R; Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, Philipp-Rosenthal-Str. 23, 04103 Leipzig, Germany.
  • Gussek P; Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, Philipp-Rosenthal-Str. 23, 04103 Leipzig, Germany.
  • Boldt A; Institute of Clinical Immunology, University Medical Center Leipzig, Johannisallee 30, 04103 Leipzig, Germany.
  • Sack U; Institute of Clinical Immunology, University Medical Center Leipzig, Johannisallee 30, 04103 Leipzig, Germany.
  • Köhl U; Institute of Clinical Immunology, University Medical Center Leipzig, Johannisallee 30, 04103 Leipzig, Germany.
  • Lordick F; Fraunhofer Institute for Cell Therapy and Immunology (IZI), Perlickstrasse 1, 04103 Leipzig, Germany.
  • Gora T; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Diseases, University Medical Center Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany.
  • Kreuz M; University Cancer Center Leipzig (UCCL), University Medical Center Leipzig, Liebigstrasse 22, 04103 Leipzig, Germany.
  • Reiche K; Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, Philipp-Rosenthal-Str. 23, 04103 Leipzig, Germany.
  • Simon JC; Fraunhofer Institute for Cell Therapy and Immunology (IZI), Perlickstrasse 1, 04103 Leipzig, Germany.
  • Ziemer M; Institute of Clinical Immunology, University Medical Center Leipzig, Johannisallee 30, 04103 Leipzig, Germany.
  • Kunz M; Fraunhofer Institute for Cell Therapy and Immunology (IZI), Perlickstrasse 1, 04103 Leipzig, Germany.
Int J Mol Sci ; 22(15)2021 Jul 27.
Article em En | MEDLINE | ID: mdl-34360781
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Nivolumabe / Inibidores de Checkpoint Imunológico / Melanoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Nivolumabe / Inibidores de Checkpoint Imunológico / Melanoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article